Skip to main content

Peripheral Arterial Disease News

Related terms: Peripheral Artery Disease, Peripheral Vascular Disease

Key Therapy Equally Effective for Women, Men With Narrowed Leg Arteries

FRIDAY, May 3, 2024 – Peripheral artery disease (PAD) involves a debilitating narrowing of arteries in the legs, and the National Institutes of Health estimates that 1 in every 20 Americans over 50...

Heart Attack Survivorship Tied to Long-Term Health Consequences

MONDAY, March 4, 2024 – Heart attacks are associated with an increased risk for developing other serious health conditions, such as peripheral arterial disease, renal failure, diabetes, and...

Black Patients With Peripheral Artery Disease Have Worse Outcomes

TUESDAY, July 18, 2023 – There are significant racial disparities in the diagnosis, treatment, and outcomes of peripheral artery disease (PAD), according to a study recently published in Advances in...

Black Patients Face Greater Risks From Leg Artery Blockages

FRIDAY, June 16, 2023 – A new study has unearthed significant racial disparities in both treatment and outcomes for peripheral artery disease (PAD). Black patients with this condition, where plaque...

Marijuana Users Have Triple the Odds for Leg Artery Disease, Study Suggests

MONDAY, May 15, 2023 – Smoking cigarettes has long been linked to peripheral artery disease (PAD), a condition where the buildup of plaque narrows arteries and limits blood flow to the legs or arms....

FDA Approves Xarelto to Reduce the Risk of Major Cardiovascular Events in Patients with Chronic Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD)

TITUSVILLE, NJ, October 11, 2018 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved Xarelto (rivaroxaban) to r...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Cardiovascular Conditions and Disorders

Related drug support groups

Xarelto, Plavix, clopidogrel